25 August 2021
IMI-ECSEL – Joint Activity complementing the Trials@Home project – 2020
Improving the drug development process by supporting research and development cooperation between academia, SMEs and the biopharmaceutical industry
+33(0)1 42 54 60 64 |
contact@welcomeurope.com
Improving the drug development process by supporting research and development cooperation between academia, SMEs and the biopharmaceutical industry
EU Member States
EEA countries
Switzerland
Turkey
Objectives
* To start for the running IMI JU project (Trails@Home) and complement to and extent on the technology scan activity of the project which will identify barriers, enablers and data management for the Remore Decentralised Clinical Trials
Additional information
* This call for proposals is an open call for proposals
* Initial duration of the action: up to 3 years
* Eligibility:
– At least three legal entities. Each of the three must be established in a different Member State or associated country;
– All three legal entities must be independent of each other
* Grant amount: 5 million euros
* Co-financing rate: between 25% and 35% of the total eligible costs depending on the type of applicant
25 August 2021